Condition: Essential Tremor · Sponsor: InSightec
This is a post-market (Phase IV) randomized, controlled, blinded, multicenter study with the aim to determine the added value of staged bilateral Exablate thalamotomy compared to a group of patients on previous unilateral treatment combined with local standard medical treatment.
This description comes directly from the study's public registry record.
Pascalle Reiters · +31 653726776 · pascaller@insightec.com
Insightec · clinicalresearchquestions@insightec.com
Always discuss trial participation with your own doctor first.
| Turku University Hospital | Turku, Finland | Recruiting |
| Universitätsklinikum Schleswig-Holstein, Campus Kiel (UKSH) | Kiel, Germany | Recruiting |
| Fondazione IRCCS Istituto Neurologico Carlo Besta | Milan, Italy | Recruiting |
| Central Japan International Medical Center | Minokamo, Gifu, Japan | Not Yet Recruiting |
| Kashiwaba Neurology Hospital | Sapporo, Hokkaido, Japan | Not Yet Recruiting |
| Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai | Kita-ku, Osaka, Japan | Not Yet Recruiting |
| Germans Trias i Pujol Hospital | Badalona, Spain | Recruiting |
| HM CINAC- Hospital Universitario HM Puerta del Sur | Móstoles, Spain | Recruiting |
| Clinica Universidad de Navarra | Pamplona, Spain | Recruiting |
| Ascires Hospital_ECG Salud | Valencia, Spain | Active Not Recruiting |
| Chang Bing Show Chwan Memorial Hospital | Changhua, Taiwan | Not Yet Recruiting |
| National Taiwan University Hospital | Taipei, Taiwan | Not Yet Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06974916